- Home
- ACM vs ICLR Comparison
ACM vs ICLR Comparison
Compare ACM & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACM
- ICLR
- Stock Information
- Founded
- ACM 1980
- ICLR 1990
- Country
- ACM United States
- ICLR Ireland
- Employees
- ACM N/A
- ICLR N/A
- Industry
- ACM Military/Government/Technical
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ACM Consumer Discretionary
- ICLR Health Care
- Exchange
- ACM Nasdaq
- ICLR Nasdaq
- Market Cap
- ACM 15.4B
- ICLR 17.2B
- IPO Year
- ACM 2007
- ICLR 1998
- Fundamental
- Price
- ACM $109.03
- ICLR $198.11
- Analyst Decision
- ACM Strong Buy
- ICLR Strong Buy
- Analyst Count
- ACM 8
- ICLR 12
- Target Price
- ACM $119.25
- ICLR $284.82
- AVG Volume (30 Days)
- ACM 903.6K
- ICLR 903.2K
- Earning Date
- ACM 02-03-2025
- ICLR 02-19-2025
- Dividend Yield
- ACM 0.95%
- ICLR N/A
- EPS Growth
- ACM 655.22
- ICLR 44.49
- EPS
- ACM 2.95
- ICLR 8.99
- Revenue
- ACM $16,105,498,000.00
- ICLR $8,306,823,000.00
- Revenue This Year
- ACM $6.98
- ICLR $3.95
- Revenue Next Year
- ACM $5.22
- ICLR $2.84
- P/E Ratio
- ACM $29.36
- ICLR $22.04
- Revenue Growth
- ACM 12.01
- ICLR 3.63
- 52 Week Low
- ACM $82.23
- ICLR $183.38
- 52 Week High
- ACM $118.56
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- ACM 50.90
- ICLR 35.86
- Support Level
- ACM $106.22
- ICLR $196.50
- Resistance Level
- ACM $111.25
- ICLR $228.29
- Average True Range (ATR)
- ACM 2.15
- ICLR 6.57
- MACD
- ACM 0.29
- ICLR -1.36
- Stochastic Oscillator
- ACM 64.25
- ICLR 5.06
About ACM AECOM
Aecom is one of the largest global providers of design, engineering, construction, and management services. It serves a broad spectrum of end markets including infrastructure, water, transportation, and energy. Based in Los Angeles, Aecom has a presence in over 150 countries and employs 51,000. The company generated $16.1 billion in sales in fiscal 2024.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.